Utilization of recombinant activated factor VII for intracranial hematoma evacuation in coagulopathic nonhemophilic neurosurgical patients with normal international normalized ratios

被引：0

作者：

Shearwood McClelland

Eun Kyung Won

Cornelius H. Lam

机构：

[1] University of Minnesota,Department of Neurosurgery

来源：

Neurocritical Care | 2007年 / 7卷

关键词：

Recombinant activated factor VII; International normalized ratio; Chronic subdural hematoma; Epidural hematoma; Nonhemophilic;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：136 / 139

页数：3

共 27 条

[21] Efficacy of recombinant activated factor VII (NovoSeven) in two patients affected by acquired hemophilia with retroperitoneal hematoma
Ciavarella, N
Schiavoni, M
Ettorre, C
Gilibertri, MG
Mascolo, E
Stefanile, C
Valenzano, E
[J]. THROMBOSIS AND HAEMOSTASIS, 1997, : PS346 - PS346
[22] RECOMBINANT ACTIVATED FACTOR-VII (RFVIIA) THERAPY FOR INTRACRANIAL HEMORRHAGE IN HEMOPHILIA-A PATIENTS WITH INHIBITORS
SCHMIDT, ML
GAMERMAN, S
SMITH, HE
SCOTT, JP
DIMICHELE, DM
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (01) : 36 - 40
[23] Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects
Sorensen, B
Johansen, P
Nielsen, GL
Sorensen, JC
Ingerslev, J
[J]. BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (05) : 469 - 477
[24] RECOMBINANT ACTIVATED FACTOR VII UTILIZATION PATTERNS AND THROMBOEMBOLIC EVENT INCIDENCE IN CRITICALLY ILL INTENSIVE CARE UNIT PATIENTS
Brophv, Gretchen M.
Robles, Jamie R.
[J]. CRITICAL CARE MEDICINE, 2008, 36 (12) : A82 - A82
[25] Experience of recombinant activated factor VII (NovoSeven®) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients
Felfernig, Michael
Huepfl, Michael
[J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2008, 110 (03) : 227 - 232
[26] Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors - Results of the NovoSeven emergency-use program
Arkin, S
Cooper, HA
Hutter, JJ
Miller, S
Schmidt, ML
Seibel, NL
Shapiro, A
Warrier, I
[J]. HAEMOSTASIS, 1998, 28 (02) : 93 - 98
[27] Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE)
Gruppo, R. A.
Kessler, C. M.
Neufeld, E. J.
Cooper, D. L.
[J]. HAEMOPHILIA, 2013, 19 (04) : 524 - 532

← 1 2 3 →